While numerous studies have elucidated the roles of PCSK9 in altering LDL cholesterol plasma levels, via the PCSK9–LDLR axis, studies on its association with platelet activation-induced myocardial infarction (MI) are still very limited. This evidence concerns the gene PCSK9 and myocardial infarction.